Reneo Pharmaceuticals, Inc. (RPHM) Financials

RPHM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 130.4 million 15.4 million
2023-06-30 148.0 million 15.5 million
2023-03-31 98.9 million 11.8 million
2022-12-31 108.2 million 8.2 million

RPHM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -18.8 million 1.4 million
2023-06-30 -16.1 million 1.2 million
2023-03-31 -9.2 million 1.2 million
2022-12-31 -15.9 million 1.2 million

RPHM Net Income

No data available :(

RPHM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 125.6 million - 1.1 million
2023-06-30 142.7 million - 1.2 million
2023-03-31 93.8 million - 1.3 million
2022-12-31 101.2 million - 1.5 million

RPHM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 33.8 million
2023-06-30 30.2 million
2023-03-31 25.0 million
2022-12-31 24.5 million

RPHM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 19000 13.6 million 7.3 million -
2023-06-30 5000 14.4 million 6.6 million -
2023-03-31 172000 11.0 million 5.1 million -
2022-12-31 250000 10.4 million 4.2 million -

RPHM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 43000
2023-06-30 - 163000
2023-03-31 - 161000
2022-12-31 - 128000

RPHM

Price: $1.73

52 week price:
0.98
11.30

Earnings Per Share: -2.52 USD

P/E Ratio: -0.74

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 37300

Market Capitalization: 56.1 million

Links: